CorMedix (CRMD) Change in Account Payables (2010 - 2025)
CorMedix (CRMD) reported Change in Account Payables of -$7.3 million for Q4 2025, down 2033.02% on a YoY basis from $375851.0 in Q4 2024, and down 211.79% sequentially from $6.5 million in Q3 2025.
CorMedix (CRMD) Change in Account Payables (2010 - 2025) Analysis & Trends
CorMedix (CRMD) has 14 years of Change in Account Payables data on file, last reported at -$7.3 million in Q4 2025.
- For the quarter ending Q4 2025, Change in Account Payables fell 2033.02% year-over-year to -$7.3 million; the trailing twelve-month figure through Dec 2025 stood at $3.3 million (up 230.04% YoY), and the FY2025 full-year result was $3.3 million, up 230.04% from the prior year.
- Change in Account Payables slipped to -$7.3 million in Q4 2025, from $6.5 million in the prior quarter.
- In the past five years, Change in Account Payables ranged from a high of $6.5 million in Q3 2025 to a low of -$7.3 million in Q4 2025.
- A 4-year average of $252402.5 and a median of $375851.0 in 2024 frame the typical range for Change in Account Payables.
- Peak annual rise in Change in Account Payables reached 648.76% in 2025, while the deepest fall reached 2033.02% in 2025.
- Tracing CRMD's Change in Account Payables over 4 years: stood at $434753.0 in 2022, then soared by 335.55% to $1.9 million in 2023, then sank by 80.15% to $375851.0 in 2024, then tumbled by 2033.02% to -$7.3 million in 2025.
- Business Quant data shows CRMD's Change in Account Payables at -$7.3 million in Q4 2025, $6.5 million in Q3 2025, and $3.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | CorMedix | 546.82 Mn | 391.62 Mn | 107.31 Mn | -7.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -7.27 Mn |
| Dec 31, 2025 | -7.27 Mn |
| Sep 30, 2025 | 6.50 Mn |
| Sep 30, 2025 | 6.50 Mn |
| Jun 30, 2025 | 3.88 Mn |
| Jun 30, 2025 | 3.88 Mn |
| Mar 31, 2025 | 212,950.00 |
| Mar 31, 2025 | 212,950.00 |
| Dec 31, 2024 | 375,851.00 |
| Dec 31, 2024 | 375,851.00 |
| Sep 30, 2024 | -2.00 Mn |
| Sep 30, 2024 | -2.00 Mn |
| Jun 30, 2024 | 518,482.00 |
| Jun 30, 2024 | 518,482.00 |
| Mar 31, 2024 | -1.45 Mn |
| Mar 31, 2024 | -1.45 Mn |
| Dec 31, 2023 | 1.89 Mn |
| Dec 31, 2023 | 1.89 Mn |
| Sep 30, 2023 | -514,450.00 |
| Sep 30, 2023 | -514,450.00 |